MORGAN STANLEY PLC/CALL/MERCK & CO./160/0.1/21.06.24 Share Price

Warrant

DE000MD9TGU6

Market Closed - Bid/Ask 01:45:38 21/05/2024 pm IST After market 11:56:13 pm
0.004 EUR -73.33% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./160/0.1/21.06.24 0.026 +550.00%
Current month-37.50%
1 month-40.00%
Date Price Change
21/24/21 0.004 -73.33%
20/24/20 0.015 0.00%
17/24/17 0.015 +7.14%
16/24/16 0.014 -12.50%
15/24/15 0.016 0.00%

Delayed Quote Börse Stuttgart

Last update May 21, 2024 at 01:45 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MD9TGU
ISINDE000MD9TGU6
Date issued 26/10/2022
Strike 160 $
Maturity 21/06/2024 (31 Days)
Parity 10 : 1
Emission price 0.14
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.29
Lowest since issue 0.001
Spread 0.028
Spread %70.00%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131 USD
Average target price
141.6 USD
Spread / Average Target
+8.13%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW